Osteoporosis Treatment Market Size Projected to Garner USD 17.1 Billion by 2030 growing at 3.9% CAGR - Exclusive Report by Acumen Research and Consulting

Author: Acumen Research and Consulting

According to Acumen Research & Consulting, the global Osteoporosis Treatment Market size was worth USD 12.2 Billion in 2021 and is projected to be worth around USD 17.1 Billion by 2030, growing at a CAGR of 3.9% in the coming years

Osteoporosis Treatment Market Overview

Growing awareness of the risks of osteoporosis and the significance of treatment is driving market demand for effective treatments. This trend is likely to continue as more patients become aware of the risks of osteoporosis and the necessity for treatment. Furthermore, technological advancements are changing the way osteoporosis treatments are delivered and managed, and this trend is expected to continue in the coming years. For example, advances in digital health technology are making it simpler for healthcare providers to monitor and manage osteoporosis patients, which are expected to drive market growth.

Osteoporosis Treatment Market Overview

Osteoporosis Treatment Market Statistics

  • Global osteoporosis treatment market value collected USD 12.2 Billion in 2021, with a 3.9% CAGR between 2022 and 2030
  • The North American osteoporosis treatment market occupied over 39% share in 2021
  • Asia-Pacific osteoporosis treatment market growth is projected to record above 4% CAGR from 2022 to 2030
  • Based on drug class, the bisphosphonate sub-segment gathered over US$ 4.9 billion in 2021
  • Among distribution channels, the hospital pharmacies sub-segment covered over 46% in 2021
  • The increased focus on patient outcomes is a key trend in the osteoporosis treatment market that fuels the industry demand

Request for a sample of this premium research report@ https://www.acumenresearchandconsulting.com/request-sample/3130

Osteoporosis Treatment Market Dynamics

With advancements in genetic testing and data analysis, healthcare providers can identify patients at high risk for osteoporosis and tailor treatment plans accordingly. This trend toward personalized medicine is expected to shape the osteoporosis treatment market in the coming years.

Pharmaceutical companies continue to prioritize research and development into new osteoporosis treatments, and new treatments are being developed and approved for use. This is propelling market growth and increasing patient access to effective treatments.

Healthcare providers are progressively focused on improving patient outcomes, which is resulting in a greater emphasis on the use of effective osteoporosis treatments. This trend is expected to continue shaping the market in the coming years, as healthcare providers aspire to provide the best possible care to their patients.

The approval process for new osteoporosis treatments, on the other hand, is stringent, which may limit the introduction of new products and market growth. However, reimbursement policies for osteoporosis treatments differ by country and may limit access to treatments, particularly in low-income countries. Furthermore, some osteoporosis treatments have been linked to severe side effects such as jaw osteonecrosis and atypical fractures. This could reduce demand for certain treatments.

Osteoporosis Treatment Market Segmentation

The global osteoporosis treatment market is categorized into drug class, route of administration, distribution channel, and geography.

  • Based on the drug class, the market is split into Bisphosphonate (alendronate, risedronate, ibandronate, zoledronic acid, and others), calcitonin, hormone replacement therapy, parathyroid hormone-related protein (PTHrP) analog, RANK ligand (RANKL) inhibitor, and selective estrogen receptor modulator (SERMs)
  • By route of administration, the classification comprises oral, injectables, and others
  • The distribution channel segment is sub-segmented into hospital pharmacies, retail pharmacies and stores, and online pharmacies
  • The regional market is classified into North America, Latin America, Asia-Pacific, Europe, and the Middle East & Africa

Osteoporosis Treatment Market Share

The bisphosphonate sub-segment is expected to lead the osteoporosis treatment market from 2022 to 2030, according to market forecasts. Based on route of administration, the oral sub segment is expected to grow at a significant rate over the forecast timeframe. Furthermore, according to the osteoporosis treatment industry analysis, hospital pharmacies commanded the highest market shares in 2021 and are expected to continue to do so in the coming years.

Osteoporosis Treatment Market Regional Outlook

In North America, the market for osteoporosis treatment is dominated by the United States, which accounts for the majority of the region's sales and revenue. The US market is characterized by a strong healthcare system, high levels of patient awareness, and a well-established pharmaceutical industry. Other countries in the North American region, such as Canada, also have well-developed markets for osteoporosis treatment, with a growing demand for effective treatments.

In the Asia-Pacific region, the market for osteoporosis treatment is dominated by China and India, which are among the largest and most populous countries in the world. These countries have large and growing populations of older people and an increasing awareness of the risks of osteoporosis and the importance of treatment. Other countries in the region, such as Japan, South Korea, and Australia, also have well-established markets for osteoporosis treatment, with a growing demand for effective treatments.

Osteoporosis Treatment Market Players

Some prominent osteoporosis treatment companies covered in the industry are Amgen Inc., Asahi Kasei Corporation, DAIICHI SANKYO COMPANY, LIMITED, Dr. Reddy’s Laboratories Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GSK plc., Ligand Pharmaceuticals Incorporated, Merck & Co., Inc., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Viatris Inc.

Click here to buy the Premium Market Research report https://www.acumenresearchandconsulting.com/buy-now/0/3130

Receive our personalized services and customization by clicking here https://www.acumenresearchandconsulting.com/request-customization/3130

Mr. Frank Wilson

Acumen Research and Consulting

USA: +13474743864

India: +918983225533

E-mail: sales@acumenresearchandconsulting.com